Background illustration for clinical trials search

Paid Clinical Trials Denver

Discover 1,550 paid clinical trials in Denver, Colorado. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.

Filter
2

Phase 1b Study of OP-1250 (Palazestrant) in Combination With Ribociclib, Alpelisib, Everolimus, or Atirmociclib in ER+, HER2- Breast Cancer

for
Metastatic Breast Cancer, ER-positive Breast Cancer,
Location: Aurora CO, Gilbert AZ, Minneapolis MN, Iowa City IA,
Sponsor: Olema Pharmaceuticals, Inc.

Sex: All

Age: 18+

Code: NCT05508906

Phase1, Recruiting

Evaluating BL-M14D1 in Subjects With Locally Advanced or Metastatic Small Cell Lung Cancer and Neuroendocrine Tumors

for
Small Cell Lung Cancer Metastatic or Locally Advanced,
Location: Aurora CO, Dallas TX, San Antonio TX, Los Angeles CA,
Sponsor: SystImmune Inc.

Sex: All

Age: 18+

Code: NCT07080242

Phase1, Recruiting

Study of Opevesostat (MK-5684) Versus Alternative NHA in mCRPC (MK-5684-003)

for
Prostate Cancer Metastatic
Location: Aurora CO, Highlands Ranch CO, Lone Tree CO, Pierre SD,
Sponsor: Merck Sharp & Dohme LLC

Sex: All

Age: 18+

Code: NCT06136624

Phase3, Recruiting

Intraperitoneal Paclitaxel With NALIRIFOX for Pancreatic Ductal Adenocarcinoma With Peritoneal Carcinomatosis

for
Pancreatic Ductal Adenocarcinoma (PDAC)
Location: Aurora CO
Sponsor: University of Colorado, Denver

Sex: All

Age: 18+

Code: NCT07030283

Phase1, Recruiting

A Clinical Trial of Elsunersen in Pediatric SCN2A-DEE to Assess Efficacy and Safety

for
Epileptic Encephalopathy, SCN2A Encephalopathy
Location: Aurora CO, San Diego CA, Memphis TN, Chicago IL,
Sponsor: Praxis Precision Medicines

Sex: All

Age: 0 - 18

Code: NCT07019922

Phase3, Recruiting

Interested in new trials?

Get alerts for new trials in your area by subscribing now

Subscriber Image

A Clinical Study of Gocatamig (MK-6070) and Infinatamab Deruxtecan (MK-2400) in People With Small Cell Lung Cancer (MK-6070-003)

for
Small Cell Lung Cancer Extensive Stage
Location: Aurora CO, Sioux Falls SD, St Louis MO, Memphis TN,
Sponsor: Merck Sharp & Dohme LLC

Sex: All

Age: 18+

Code: NCT07227597

Phase1, Phase2, Recruiting

Eganelisib as Monotherapy and in Combination With Cytarabine in Relapsed/Refractory AML

for
AML, Adult, MDS
Location: Aurora CO, St Louis MO, Duarte CA, Houston TX,
Sponsor: Stelexis BioSciences

Sex: All

Age: 18+

Code: NCT06533761

Phase1, Recruiting

Effect of Dalcetrapib on CV Risk in a Genetically Defined Population With a Recent ACS

for
Acute Coronary Syndrome
Location: Aurora CO, Golden CO, Rapid City SD, Albuquerque NM,
Sponsor: DalCor Pharmaceuticals

Sex: All

Age: 45+

Code: NCT05918861

Phase3, Recruiting

Atypical Hemolytic-Uremic Syndrome (aHUS) Registry

for
Atypical Hemolytic-Uremic Syndrome
Location: Aurora CO, St Louis MO, Atlanta GA, London, Toronto,
Sponsor: Alexion Pharmaceuticals, Inc.

Sex: All

Age: 0+

Code: NCT01522183

Recruiting

Study of Elironrasib and Daraxonrasib as Monotherapies and Combination Therapy in Participants With Advanced KRAS G12C Mutant Solid Tumors

for
Non-Small Cell Lung Cancer (NSCLC), Colorectal Cancer,
Location: Aurora CO, Oklahoma City OK, Irving TX, San Antonio TX,
Sponsor: Revolution Medicines, Inc.

Sex: All

Age: 18+

Code: NCT06128551

Phase1, Phase2, Recruiting

Study to Evaluate Maximum Tolerated Dose of Oral CB-03-10 With Dose Expansion Phase, in Advanced Solid Tumors

for
Advanced Refractory Solid Tumors,
Location: Colorado Springs CO, California City CA, Texas City TX,
Sponsor: Cosmo Technologies Ltd

Sex: All

Age: 18+

Code: NCT03863145

Early_phase1, Recruiting

A Phase I/II Study of VLS-1488 in Subjects With Advanced Cancer

for
Advanced Solid Tumor, High Grade Serous Adenocarcinoma of Ovary,
Location: Aurora CO, Newport Beach CA, Los Angeles CA, Houston TX,
Sponsor: Volastra Therapeutics, Inc.

Sex: All

Age: 18+

Code: NCT05902988

Phase1, Phase2, Recruiting

A Phase 1/1b Study of IAM1363 in HER2 Cancers

for
HER2 Mutation-Related Tumors, HER2, HER2-positive Breast Cancer,
Location: Aurora CO, West Valley City UT, Oklahoma City OK,
Sponsor: Iambic Therapeutics, Inc

Sex: All

Age: 18+

Code: NCT06253871

Phase1, Recruiting

Efficacy and Safety of Extended TARPEYO® Treatment Beyond 9 Months in Adult Patients With Primary IgA Nephropathy

for
IgA Nephropathy
Location: Aurora CO, Albuquerque NM, El Paso TX, Odessa TX,
Sponsor: Calliditas Therapeutics AB

Sex: All

Age: 18+

Code: NCT06712407

Recruiting

Ivosidenib in Participants With Locally Advanced or Metastatic Conventional Chondrosarcoma Untreated or Previously Treated With 1 Systemic Treatment Regimen

for
Locally Advanced or Metastatic Conventional Chondrosarcoma With an IDH1 Mutation, Untreated or Previously Treated With 1 Systemic Treatment Regimen,
Location: Aurora CO, Omaha NE, Rochester MN, Iowa City IA,
Sponsor: Servier Bio-Innovation LLC

Sex: All

Age: 18+

Code: NCT06127407

Phase3, Recruiting

CtDNA Based MRD Testing for NAC Monitoring in TNBC

for
TNBC - Triple-Negative Breast Cancer, Minimal Residual Disease
Location: Aurora CO, Omaha NE, Tucson AZ, Peoria IL, Spokane WA,
Sponsor: Personalis Inc.

Sex: Female

Age: 18+

Code: NCT06230185

Recruiting

Specimen Banking From Patients With Lung Cancer

for
Lung Neoplasms
Location: Aurora CO
Sponsor: University of Colorado, Denver

Sex: All

Age: 18 - 70+

Code: NCT01585675

Recruiting

Study to Compare the Overall Survival of Patients Receiving INGN 201 (Study Drug) With Patients Receiving Methotrexate

for
Carcinoma, Squamous Cell
Location: Aurora CO, Dallas TX, Louisville KY, Columbia SC,
Sponsor: Introgen Therapeutics

Sex: All

Age: 18+

Code: NCT00041613

Phase3, Recruiting

Long-term Safety and Efficacy Extension Study for Participants With Advanced Tumors Who Are Currently on Treatment or in Follow-up in a Pembrolizumab (MK-3475) Study (MK-3475-587/KEYNOTE-587)

for
Solid Tumors, Hematologic Malignancies
Location: Aurora CO, Tulsa OK, Las Vegas NV, Tucson AZ, Dallas TX,
Sponsor: Merck Sharp & Dohme LLC

Sex: All

Age: 18+

Code: NCT03486873

Phase3, Recruiting

A Clinical Study to Investigate the Efficacy and Safety of an Investigational Combination Therapy With BNT324 and BNT327 in Patients With Advanced Lung Cancer

for
Advanced Lung Cancer
Location: Aurora CO, Phoenix AZ, Dallas TX, Rochester MN,
Sponsor: BioNTech SE

Sex: All

Age: 18+

Code: NCT06892548

Phase1, Phase2, Recruiting

Denver is a pivotal hub for clinical trials, thanks to its sturdy healthcare network and renowned medical research institutions. Prominent centers such as the University of Colorado Anschutz Medical Campus, Denver Health, and Children’s Hospital Colorado are at the forefront of groundbreaking studies focusing on areas including cancer research, neurological disorders, and chronic diseases.

Denver's strong emphasis on collaboration among healthcare providers, researchers, and community organizations fosters an environment conducive to medical advancements. By participating in clinical trials in Denver, individuals not only gain access to cutting-edge therapies but also contribute significantly to the progress of medical science.

Why choose Denver for clinical trials?

Denver boasts a diverse population which helps increase the reliability and relevance of research outcomes. The city is also home to top-tier medical research facilities known for innovative approaches to healthcare and a strong emphasis on medical breakthroughs.

Choosing to participate in a clinical trial in Denver means contributing to vital medical research while benefiting from a well-coordinated and supportive clinical research infrastructure. This environment not only promotes advancements in medical science but also provides participants with access to pioneering therapies and specialized care throughout the study.

Common conditions studied in Denver

Local regulations and guidelines

Benefits of participating in clinical trials

How to enroll in a clinical trial in Denver